Stomach Cancer Trial, Recruiting NCT06679244 Sponsor: Huashan Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06679244
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old
  • People whose stomach cancer tumour is located in the upper part of the stomach or at the junction where the oesophagus meets the stomach (a specific type called Siewert II or III), and where surgery is expected to fully remove the tumour
  • People whose tumour has been confirmed as a type called adenocarcinoma through a biopsy and laboratory testing
  • People with upper stomach adenocarcinoma at an early, localised stage (cT1N0M0), or people with adenocarcinoma at the oesophagus-stomach junction at a stage of cT1-3N0-1M0, with no signs of cancer spreading to distant lymph nodes on imaging
  • People whose life expectancy is longer than 6 months
  • People who have not had previous upper abdominal surgery (having had a laparoscopic gallbladder removal is acceptable)
  • People who have not received chemotherapy, radiotherapy, targeted therapy, or immunotherapy before surgery
  • People with a good general physical fitness level, as measured by standard medical scoring tools before surgery (ECOG score of 0 or 1, and ASA grade I–III)
  • People whose heart, liver, kidneys, and other major organs are functioning well
  • People who are willing to sign a consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose pre-surgery scans show enlarged lymph nodes in the area that have merged together, with the largest being 3 cm or more
  • People who are pregnant or breastfeeding
  • People who have had another type of cancer in the past 5 years
  • People with a body temperature of 38°C or higher before surgery, or who have an infection that requires treatment
  • People with a serious mental illness
  • People with severe lung disease where breathing test results fall below 50% of the expected level
  • People with severe liver or kidney problems
  • People who have had unstable chest pain (angina) or a heart attack within the past 6 months
  • People who have had a stroke or brain bleed within the past 6 months (confirm with trial site regarding specific exceptions)
  • People who have used steroid medications (taken throughout the body, not just on the skin) within the past month
  • People who need emergency surgery due to complications of stomach cancer such as bleeding, a perforation, or a blockage
  • People who have taken part in, or are currently taking part in, another clinical trial within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18121186328

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Huashan Hospital
Registry
ClinicalTrials.gov
Start date
4 December 2024
Est. completion
1 June 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

body weight loss(BWL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov